The Business of COVID-19
Thursday, September 10, 7 pm ET on Zoom
On Thursday, September 10, Science Writers in New York invites you to join us on Zoom for a conversation with SWINY co-chair David Levine (@dlloydlevine) and Ed Silverman (@EdSilverman), senior writer and Pharmalot (@pharmalot) columnist at STAT News and its expert on the pharmaceutical industry.
Davis and Ed will discuss the business side of COVID-19:
- Why is the FDA a flashpoint and is it too late to change course before the election?
- What are the issues with an Emergency Use Authorization for a COVID-19 vaccine?
- What should Operation Warp Speed do to ensure therapies and vaccines are affordable?
- Will Washington do anything about drug pricing?
Do you have a question for Ed Silverman you would like answered? Submit it here.
Ed Silverman is a senior writer and Pharmalot columnist at STAT. Ed has covered the pharmaceutical industry for the past two decades. He previously worked at The Wall Street Journal, The Star-Ledger of New Jersey, New York Newsday and Investor’s Business Daily, among other publications. He won the Gerald Loeb Award for business and financial journalism in 2018 for his Pharmalot View columns. Along with several former Wall Street Journal colleagues, Ed was a Pulitzer Prize finalist in explanatory journalism for a series of stories on prescription pricing. He earned an accounting degree from Binghamton University and a master’s in journalism from New York University.
Thursday, September 10
7 to 8 pm ET
Here are a few of Ed’s recent Pharmalot columns: